文献速递其他结缔组织病

阿拉斯加原住民与美洲印第安人群体中舍格伦病的患病率与发病率

Prevalence and Incidence of Sjögren's Disease in Alaska Native and American Indian Peoples of Alaska.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2025-11-15

本研究通过查询阿拉斯加部落卫生系统电子健康记录,纳入由风湿免疫科医生诊断的舍格伦病成人患者,计算年龄标化患病率和发病率。年龄标化患病率为每10万成人199例(95%CI 170-231),发病率为每10万人年16.6例(95%CI 13.7-20.0)。仅5%接受唾液腺活检,仅3%符合2016年ACR/EULAR或2012年ACR标准。

要点

  • 阿拉斯加原住民与美洲印第安人舍格伦病年龄标化患病率为每10万成人199例(95%CI 170-231)。
  • 原发性舍格伦病患病率为每10万成人129例(95%CI 106-155),继发性为70例(95%CI 54-91)。
  • 2012至2019年年龄标化发病率为每10万人年16.6例(95%CI 13.7-20.0)。

核心结论

  • 阿拉斯加原住民与美洲印第安人中舍格伦病的患病率和发病率高于其他人群,这些结果可能有助于临床医生识别和治疗该病。

研究设计与样本

  • 通过查询阿拉斯加部落卫生系统内参与部落卫生组织的电子健康记录,识别由风湿免疫科医生诊断的舍格伦病成人患者。
  • 患病率使用2019年阿拉斯加部落卫生系统用户人口计算点患病率,发病率计算2012年至2019年期间,均直接年龄标化至2000年美国标准人口。

主要发现

  • 舍格伦病年龄标化患病率为每10万成人199例(95%CI 170-231)。
  • 原发性舍格伦病年龄标化患病率为每10万成人129例(95%CI 106-155),继发性为70例(95%CI 54-91)。
  • 2012年至2019年年龄标化发病率为每10万人年16.6例(95%CI 13.7-20.0)。
  • 66%的成人符合修改标准(Ro/SSA抗原阳性伴干燥症状),仅5%接受唾液腺活检,仅3%符合2016年ACR/EULAR或2012年ACR标准。
  • 继发性舍格伦病最常见的相关疾病为类风湿关节炎和系统性红斑狼疮。

关键数值与推荐

  • 修改标准定义为Ro/SSA抗原阳性伴干燥症状,66%的成人符合。
  • 2016年ACR/EULAR标准和2012年ACR标准均仅3%的成人符合。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Our objective was to determine the prevalence, incidence, and clinical characteristics of Sjögren's disease (SjD) in Alaska Native and American Indian (AN/AI) peoples of Alaska. METHODS: We identified adults with SjD by querying electronic health records from participating tribal health organizations within the Alaska Tribal Health System (ATHS). Medical records were abstracted for adults with diagnostic codes for SjD. Individuals were included if they were diagnosed with SjD by a rheumatologist. Prevalence and incidence were calculated using the ATHS user population in 2019 (point prevalence) and from 2012 to 2019 (incidence), with direct age adjustment to the 2000 standard US population. We evaluated whether adults met modified criteria (positive Ro/SSA antigen with sicca symptoms), 2016 American College of Rheumatology (ACR)/EULAR, and 2012 ACR criteria. RESULTS: The age-adjusted prevalence of SjD was 199 per 100,000 adults (95% confidence interval [CI] 170-231); for primary SjD, it was 129 (106, 155), and for secondary SjD, it was 70 (95% CI 54-91). The age-adjusted incidence over the period was 16.6 (95% CI 13.7-20.0) per 100,000 person-years. Two-thirds (66%) of adults met modified criteria. Only 5% had a salivary gland biopsy performed, and only 3% met the 2016 ACR/EULAR or 2012 ACR criteria. The most common associated conditions in secondary SjD were rheumatoid arthritis and systemic lupus erythematosus. CONCLUSION: The prevalence and incidence of SjD in AN/AI peoples is higher than other populations. These results may help clinicians to identify and treat this condition.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Morrison T, Holck P, Choromanski TL, et al. Prevalence and Incidence of Sjögren's Disease in Alaska Native and American Indian Peoples of Alaska. Arthritis Care Res (Hoboken). 2025. PMID: 40621811. doi:10.1002/acr.25600

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。